Navigation Links
Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
Date:9/1/2011

SAN DIEGO, Sept. 1, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Stifel Nicolaus 2011 Healthcare Conference in Boston.  

The live presentation takes place on Thursday, September 8, 2011 at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
2. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
3. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
4. Neurocrine Biosciences to Present at the Deutsche Bank 36th Annual Healthcare Conference
5. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
6. Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference
7. Neurocrine Biosciences to Present at Citis 2011 Global Health Care Conference
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
9. Neurocrine Biosciences Reports Third Quarter 2010 Results
10. Neurocrine Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
11. Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... España, September 2, 2014 ... fibrilación atrial muestran agentes antitrombóticos no utilizados óptimamente ... -- Las presentaciones de GARFIELD-AF en el ... tratamiento y los resultados de pacientes en riesgo ... --    Los datos de casi ...
(Date:9/2/2014)... Spain , September 2, 2014 ... at ESC CONGRESS 2014 provide insight into treatment ... in everyday clinical practice --   ... Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), ... that stroke prevention strategies for atrial fibrillation (AF) ...
(Date:9/2/2014)... VIEJO, Calif. , Sept. 2, 2014  Avanir Pharmaceuticals, ... management will present an overview of the company at the ... . , Presentation date: Tuesday September 9, ... A live webcast and 30-day archive of this ... About Avanir Pharmaceuticals, Inc. Avanir Pharmaceuticals, Inc. ...
Breaking Medicine Technology:Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9
... to treating MCLs nonsurgically, study findsROSEMONT, Ill., March 2 ... ligament (MCL) may be treated successfully without surgery, according ... issue of The Journal of the American Academy ... the review,s authors found, is properly diagnosing and understanding ...
... (Nasdaq: ARAY ), a global leader in ... CyberKnife lung cancer treatments in calendar year 2008. ... radiosurgery in the United States grew 52 percent from ... Additionally the overall number of patients treated with ...
Cached Medicine Technology:Treating Knee Ligament Injuries 2Treating Knee Ligament Injuries 3CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth 2CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth 3CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth 4
(Date:9/2/2014)... 02, 2014 Becker's Healthcare is ... and Chief Information Officer Strategy Roundtables on November ... Becker's Hospital Review Chief Executive Officer and Chief ... health system Chief Executive Officers, Chief Financial Officers, ... system executives through high-quality continuing education, networking ...
(Date:9/2/2014)... BambooIndustry.com, an excellent company in the bamboo industry, has ... floors to celebrate the coming of autumn. To ... frequent callers, BambooIndustry.com launched a promotion for its newly ... floors, BambooIndustry.com provides many kinds of wonderful items for ... floors, click lock floors, wide plank floors and so ...
(Date:9/2/2014)... pm EDT): In a Viewpoint published today in the ... team of Boston researchers call for the implementation of ... United States. The researchers from the Friedman School of ... and Boston Children,s Hospital write that policies taxing nearly ... help people make meaningful dietary changes and substantially reduce ...
(Date:9/2/2014)... 2014 TCG, a leading government technology strategy ... one of the fastest-growing companies in America for the seventh ... was previously recognized in 2013, 2012, 2011, 2010, 2009, 2008, ... grown 86% from 2010 to 2013, ranking the company at ... in America - up 635 spots from 2013! More information ...
(Date:9/2/2014)... New York, NY (PRWEB) September 02, 2014 ... and other new blood thinners is growing at a ... ) continue to mount in courts around the U.S., ... published in American Journal of Medicine, within a year ... to be prescribed Xarelto as warfarin, a blood thinner ...
Breaking Medicine News(10 mins):Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2Health News:Taxes and subsidies could encourage healthier diet and lower healthcare costs 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4
... that feeding tubes do not improve survival rates or ... their frequency of use varies widely across the states. ... surrounding the decision to place feeding tubes surgically are ... that often affects a patient,s ability to eat. In ...
... People with dementia may soon have improved oral hygiene ... four-year grant to Rita A. Jablonski, assistant professor of ... disease have all been linked to poor oral hygiene. ... for because they often are no longer able to ...
... to predict the risk of disease progression and response ... for high- and low-risk patients, but do not always ... a new analysis shows. In recent years, ... information for breast cancer. Dr Catherine Kelly from Mater ...
... COLUMBUS, Ohio In a rare and medically remarkable operation, ... Comprehensive Cancer Center Arthur G. James Cancer Hospital and ... left leg, hip and pelvis of a cancer patient, and ... completely rebuild the connection between his spine and remaining right ...
... 4 (HealthDay News) -- U.S. health officials issued final ... liquid over-the-counter drug products that are measured and dispensed ... The U.S. Food and Drug Administration developed the ... overdoses when using liquid over-the-counter (OTC) pain relievers, cold ...
... WEDNESDAY, May 4 (HealthDay News) -- A gene essential to ... heart defects that cause a major proportion of childhood death ... cardiac defects -- all malformations of the left ventricular outflow ... component may play a role. "It is estimated that ...
Cached Medicine News:Health News:Families need to know more about feeding tubes for elderly dementia patients 2Health News:Breast cancer multi-gene tests compared 2Health News:Breast cancer multi-gene tests compared 3Health News:Ohio State surgeons rebuild pelvis of cancer patient 2Health News:Ohio State surgeons rebuild pelvis of cancer patient 3Health News:FDA Issues Guidelines for Liquid OTC Medicines 2Health News:New Gene Linked to Congenital Heart Defects 2
... Chrome-plated metal frames ... ensures optimal cleanliness and ... stools come with user-friendly ... height adjustment. Fixed footring ...
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
Inquire...
Medicine Products: